תחשיב כלכלי – פרופ’ משה לשנו

מחקר של מודל כלכלי המראה את החשיבות של בדיקות קולונוסקופיה לאוכלוסיה הבריאה גם מהשיקול הכלכלי

פרופ' משה לשנו, נדיר ארבר, זמיר הלפרין

Health Care Management Science 6, 165–174, 2003

Cost-Effectiveness of Colorectal Cancer Screening in the Average Risk Population
MOSHE LESHNO- Faculty of Management and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel E-mail: leshnom@post.tau.ac.il

ZAMIR HALPERN and NADIR ARBER Department of Gastroenterology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel

 

Colorectal cancer (CRC) is a leading cause of cancer death in North America and in Israel. Risk of CRC increases exponentially with age starting at the age of 50 years. Therefore, people older than 50 years are being considered as an average risk population for CRC. The objective of this study was to obtain an improved assessment of the cost-effectiveness analysis of screening for CRC in the average risk population by using a more accurate technique, namely the Partially Observed Markov Decision Process (POMDP). We conducted a cost-effectiveness analysis within the specific probability rates and costs in Israel. This study revealed that it is highly cost-effective to screen average-risk asymptomatic individuals

לקריאת המאמר המלא ליחצו כאן